ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$MYGN:NASDAQ · MYRIAD GENETICS INC

Sector: health

Conviction from: NASDAQ

52-week range: 2.748.59

Myriad Genetics develops and provides molecular diagnostic and genetic tests for hereditary cancer risk, oncology, prenatal, and mental-health applications.

3 tracked filer(s) hold this · 0 opened, 0 added, 3 trimmed in 30-JUN-2026

Aggregate 13FScore 64 — mean of 3 scored holder(s). Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor63Trimmed -2%44,680$255,1230.0%
Louis Bacon / Moore53Trimmed -14%188,526$1,076,4830.0%
Steve Cohen / Point7276Trimmed -75%238,776$1,363,4110.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-02-27Phanstiel S. Louisedirector104,507$494,548Form 4

Trump & executive branch trades all Trump/exec trades →

1 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-05-14Trump, Donald J PresidentSELL$15,001 - $50,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.